Nintedanib in combination with cisplatin/gemcitabine as 1st-line therapy for advanced squamous non-small cell lung cancer
Authors
Forster, MHackshaw, A
De Pas, T
Cobo, M
Garrido, P
Summers, Yvonne J
Dingemans, A
Flynn, M
Von Wangenheim, U
Temple, G
Loembe, A
Lee, S
Affiliation
University College London Hospitals NHS Foundation TrustIssue Date
2015